ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,885, issued on July 22, was assigned to DSM IP ASSETS B.V. (Heerlen, Netherlands).
"Production of riboflavin" was invented by Christopher Mark Farrell (Kaiseraugst, Switzerland), Sebastien Eric Potot (Kaiseraugst, Switzerland), Zoltan Pragai (Kaiseraugst, Switzerland) and Michael Patrick Anaya (Kaiseraugst, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to an improved process for production of vitamin B2 using a genetically engineered host cell comprising a heterologous enzyme with pyridoxal phosphatase activity. Using said modified host cell, the yield of riboflavin production could be increased by at le...